Erythropoiesis-stimulating agents in sickle cell anaemia

被引:14
|
作者
Han, Jin [1 ,2 ,3 ]
Zhou, Jifang [3 ]
Kondragunta, Vinod [1 ]
Zhang, Xu [1 ]
Molokie, Robert E. [1 ]
Gowhari, Michel [1 ]
Hassan, Johara [1 ]
Jain, Shivi [1 ]
Calip, Gregory S. [3 ]
Gordeuk, Victor R. [1 ]
Saraf, Santosh L. [1 ]
机构
[1] Univ Illinois, Dept Med, Ctr Comprehens Sickle Cell, Div Hematol & Oncol, Chicago, IL 60607 USA
[2] Univ Illinois, Coll Pharm, Dept Pharm Practice, Chicago, IL USA
[3] Univ Illinois, Ctr Pharmacoepidemiol & Pharmacoecon Res, Chicago, IL USA
基金
美国国家卫生研究院;
关键词
sickle cell anaemia; erythropoietin; darbepoetin; erythropoiesis-stimulating agents; RECOMBINANT-HUMAN-ERYTHROPOIETIN; RENAL-FAILURE; HYDROXYUREA;
D O I
10.1111/bjh.14846
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:602 / 605
页数:4
相关论文
共 50 条
  • [41] Predictive factors for anemia response to erythropoiesis-stimulating agents in myelofibrosis
    Hernandez-Boluda, Juan-Carlos
    Correa, Juan-Gonzalo
    Garcia-Delgado, Regina
    Martinez-Lopez, Joaquin
    Alvarez-Larran, Alberto
    Fox, Maria-Laura
    Garcia-Gutierrez, Valentin
    Perez-Encinas, Manuel
    Ferrer-Marin, Francisca
    Mata-Vazquez, Maria-Isabel
    Raya, Jose-Maria
    Estrada, Natalia
    Garcia, Silvia
    Kerguelen, Ana
    Duran, Maria-Antonia
    Albors, Manuel
    Cervantes, Francisco
    EUROPEAN JOURNAL OF HAEMATOLOGY, 2017, 98 (04) : 407 - 414
  • [42] Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis
    Escudero-Vilaplana, Vicente
    Martinez-Nieto, Concepcion
    Manuel Lopez-Gomez, Juan
    Vega-Martinez, Almudena
    Maria Bellon-Cano, Jose
    Sanjurjo-Saez, Maria
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2013, 35 (03) : 463 - 468
  • [43] Erythropoiesis-stimulating agents in anaemia due to chronic kidney disease: a cost-minimization analysis
    Vicente Escudero-Vilaplana
    Concepción Martínez-Nieto
    Juan Manuel López-Gómez
    Almudena Vega-Martínez
    José María Bellón-Cano
    María Sanjurjo-Sáez
    International Journal of Clinical Pharmacy, 2013, 35 : 463 - 468
  • [44] A Literature Review-Based Clinical Guide on the Use of Erythropoiesis-Stimulating Agents (ESA) in the Treatment of Patients with Gynaecological Malignancies and Related Anaemia
    Petru, E.
    Stummvoll, W.
    Angleitner-Boubenizek, L.
    Scholl, T.
    Sevelda, P.
    Benedicic, C.
    Speiser, P.
    Reinthaller, A.
    GEBURTSHILFE UND FRAUENHEILKUNDE, 2010, 70 (08) : 646 - 657
  • [45] Effect of erythropoiesis-stimulating agents in acute ST-segment elevation myocardial infarction: a systematic review
    Li, Juan
    Xu, Huiyan
    Gao, Qian
    Wen, Yanting
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2012, 68 (05) : 469 - 477
  • [46] Erythropoiesis-stimulating agent hyporesponsiveness
    Johnson, David W.
    Pollock, Carol A.
    Macdougall, Iain C.
    NEPHROLOGY, 2007, 12 (04) : 321 - 330
  • [47] The Role of Erythropoietin and Erythropoiesis-Stimulating Agents in Tumor Progression
    Hedley, Benjamin D.
    Allan, Alison L.
    Xenocostas, Anargyros
    CLINICAL CANCER RESEARCH, 2011, 17 (20) : 6373 - 6380
  • [48] Predictors of Hyporesponsiveness to Erythropoiesis-Stimulating Agents in Hemodialysis Patients
    Kalantar-Zadeh, Kamyar
    Lee, Grace H.
    Miller, Jessica E.
    Streja, Elani
    Jing, Jennie
    Robertson, John A.
    Kovesdy, Csaba P.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2009, 53 (05) : 823 - 834
  • [49] Erythropoiesis-stimulating agents for preventing acute kidney injury
    Nishiwaki, H.
    Abe, Y.
    Suzuki, T.
    Hasegawa, T.
    Levack, W. M. M.
    Noma, H.
    Ota, E.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2024, (09):
  • [50] Pleiotropic effect of erythropoiesis-stimulating agents on circulating endothelial progenitor cells in dialysis patients
    Takashi Naito
    Manabe Shun
    Hideki Nishimura
    Tomoki Gibo
    Mai Tosaka
    Moe Kawashima
    Akitoshi Ando
    Tetsuya Ogawa
    Tsutomu Sanaka
    Kosaku Nitta
    Clinical and Experimental Nephrology, 2021, 25 : 1111 - 1120